SHP2 inhibition reduces leukemogenesis in models of combined genetic and epigenetic mutations

Journal: Journal of Clinical Investigation

Published: 2019-12-02

DOI: 10.1172/jci130520

Affiliations: 5

Authors: 7

Go to article
Institutions Share
Herman B Wells Center for Pediatric Research, IUPUI, United States of America (USA) 0.43
Department of Electrical and Computer Engineering, IUPUI, United States of America (USA) 0.14
Department of Pathology and Laboratory Medicine, IUPUI, United States of America (USA) 0.14
Novartis Institutes for Biomedical Research (NIBR), United States of America (USA) 0.14
Department of Medical and Molecular Genetics, IUPUI, United States of America (USA) 0.14

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER